Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
A. G. Loft
Observed names:
A.G. Loft,
Loft AG,
Loft, A G,
Loft, A.G.
Institutions:
Aarhus University,
Aarhus University Hospital
Observed institutions:
Aarhus University,
Aarhus University Hospital
OpenAlex ID:
A5081652841
SAT0409 Association between Tobacco Smoking and Response to Tumor Necrosis Factor Alpha Inhibitor Treatment in Psoriatic Arthritis: Results from the Danbio Registry
2014
·
P. Højgaard
, B. Glintborg
, et al.
·
Annals of the Rheumatic Diseases
·
4
Op0022 Disease Activity-guided Tapering of Biologics in Patients With Inflammatory Arthritis: a Randomised, Open-label, Equivalence Trial
2022
·
L. Uhrenholt
, R. Christensen
, et al.
·
Annals of the Rheumatic Diseases
·
2
PDF
Pos0249 Sex Differences in Patient-reported Outcomes in Axial Spondyloarthritis Patients Treated With Tumor Necrosis Factor Inhibitors: Results From a Multinational Observational Cohort Study
2023
·
P. Hellamand
, M.G.H. Van de Sande
, et al.
·
Annals of the Rheumatic Diseases
·
1
PDF
Pos0374 How Well Do Eular/asas-eular and National Treatment Recommendations for Psoriatic Arthritis and Axial Spondyloarthritis Align? Is It Time for an Update of National Treatment Recommendations?
2023
·
B. Michelsen
, M.J. Nissen
, et al.
·
Annals of the Rheumatic Diseases
·
1
PDF
AB0917 A randomized, usual care controlled, parallel-group pragmatic clinical trial in an interdisciplinary combined dermatology–gastroenterology–rheumatology clinic; preliminary data on baseline characteristics of 128 patients and questionnaire-based qualitative data from 30 patients and 15 HCPs
2022
·
T.B. Laurberg
, A.G. Loft
, et al.
·
Annals of the Rheumatic Diseases
·
1
PDF
Pos0001 Can Single Imputation Techniques for Basdai Components Reliably Calculate the Composite Score in Axial Spondyloarthritis Patients?
2022
·
S. Georgiadis
, M. Riek
, et al.
·
Annals of the Rheumatic Diseases
·
1
PDF
OP0020 SEX DIFFERENCES IN EFFECTIVENESS OF FIRST-LINE TUMOR NECROSIS FACTOR INHIBITORS IN AXIAL SPONDYLOARTHRITIS; RESULTS FROM FIFTEEN COUNTRIES IN THE EuroSpA RESEARCH COLLABORATION NETWORK
2022
·
P. Hellamand
, M.G.H. Van de Sande
, et al.
·
Annals of the Rheumatic Diseases
·
1
PDF
ABS1150 SEX-BASED DIFFERENCES IN PREDICTORS OF SECUKINUMAB EFFECTIVENESS IN EUROPEAN ROUTINE CARE PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM THE EuroSpA COLLABORATION
2025
·
J. Heberg
, S. Georgiadis
, et al.
·
Annals of the Rheumatic Diseases
Pos0797 Real-world Effectiveness of Il-17a Inhibitors in European Patients With Axial Spondyloarthritis – Impact of Previous Tnf-inhibitor Exposure
2024
·
M. Pons
, S. Georgiadis
, et al.
·
Annals of the Rheumatic Diseases
Op0183 Predictors of Secukinumab Treatment Response and Continuation in Axial Spondyloarthritis: Results From the Eurospa Research Collaboration Network
2024
·
M. Pons
, S. Georgiadis
, et al.
·
Annals of the Rheumatic Diseases
Pos0954 the Impact of Smoking Status on One-year Secukinumab Retention Rate in 1,684 Patients With Psoriatic Arthritis: Real-world Results From the Eurospa Collaboration
2024
·
Z. Faizy Ahmadzay
, S. Georgiadis
, et al.
·
Annals of the Rheumatic Diseases
Pos0656 Does Radiographic Status Impact Secukinumab Effectiveness in European Axial Spondyloarthritis Patients Treated in Routine Care?
2023
·
S.N. Christiansen
, S.H. Rasmussen
, et al.
·
Annals of the Rheumatic Diseases
PDF
POS1226 CLINICAL FACTORS ASSOCIATED WITH A POSITIVE SARS-CoV-19 TEST AND WITH FREQUENT TESTING DURING THE COVID-19 PANDEMIC IN >10.000 PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES. RESULTS FROM A NATIONWIDE SURVEY FROM THE DANISH DANBIO REGISTRY
2022
·
B. Glintborg
, D.V. Jensen
, et al.
·
Annals of the Rheumatic Diseases
PDF
Pos1197 Remote and Physical Consultations During the First 15 Months of the Covid-19 Pandemic: Use and Patient-satisfaction in Patients With Inflammatory Rheumatic Diseases Followed in the Danbio Registry
2022
·
B. Glintborg
, D.V. Jensen
, et al.
·
Annals of the Rheumatic Diseases
PDF
POS0077 SEX DIFFERENCES IN EFFECTIVENESS OF FIRST-LINE TUMOR NECROSIS FACTOR INHIBITORS IN PSORIATIC ARTHRITIS; RESULTS FROM THIRTEEN COUNTRIES IN THE EuroSpA RESEARCH COLLABORATION NETWORK
2022
·
P. Hellamand
, M.G.H. Van de Sande
, et al.
·
Annals of the Rheumatic Diseases
PDF
Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry
2017
·
Ibfelt EH
, Sørensen J
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
Show more works
View as search
Works count:
18
Citation count:
11
H-index:
2
I10-index:
Year
Topic
Type
